The object of the research proposals are directed at studying immunologic intervention in autoimmunity. The clinical focus of this program project grant is the use of immunologic intervention in the treatment of rheumatoid arthritis by the use of total lymphoid irradiation by Dr. Strober. Closely aligned with this project is the proposal by Dr. Fathman to study collagen induced arthritis in rodents as a model of inflammatory autoimmune arthritis. A variety of immunnnotherapeutic protocols have been proposed with potential direct applications to human models. The studies outlined by Dr. Parnes are intended to investigate the basic immunoregulatory pathway which seems to be perturbed by the use of total lymphoid irradiation; that is, to down regulate the expression of major histocompatibility complex antigens on cell surfaces. The other projects have as their focus, systemic lupus erythematosis. The project by Dr. McDevitt uses an experimental new protocol in immunomodulation of a murine model of systemic lupus erythematosis, the NZB/WF1 glomerulonephritis. Preliminary data from Dr. McDevitt's laboratory suggest that the use of anti-Ia antibodies will have therapeutic significance in this disease. Thus, Dr. Engleman and Grumet propose to attempt to raise human antibodies reactive within MHC determinants which might be ultimately used for immunologic intervention in human autoimmune disorders, including systemic lupus erythematosis. The major thrust of this program project grant is an attempt to transfer technology which currently exists in the immunologic community at Standard to a more direct application toward potential patient care and immunologic intervention in autoimmunity. Each of these individual projects rely upon one or more of the compananion projects. It is through this type of integrated multi-department interaction that program project grants allow interactions among investigators that transcend the usual divisional or departmental boundaries of research activities and lead to more immediate technology transfer from the lab to patient care.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI011313-13
Application #
3091419
Study Section
Allergy and Immunology Research Committee (AIRC)
Project Start
1984-09-30
Project End
1989-08-31
Budget Start
1986-09-01
Budget End
1987-08-31
Support Year
13
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Holoshitz, J; Kosek, J; Sibley, R et al. (1991) T lymphocyte-synovial fibroblast interactions induced by mycobacterial proteins in rheumatoid arthritis. Arthritis Rheum 34:679-86
Morel, P A; Horn, G T; Budd, R C et al. (1990) Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritis. Hum Immunol 27:90-9
Schwadron, R B; Palathumpat, V; Strober, S (1989) Natural suppressor cells derived from adult spleen and thymus. Transplantation 48:107-10
Jacob, C O; Holoshitz, J; Van der Meide, P et al. (1989) Heterogeneous effects of IFN-gamma in adjuvant arthritis. J Immunol 142:1500-5
Hoppe, R T (1989) Effects of irradiation on the human immune system. Front Radiat Ther Oncol 23:140-9
Chao, N J; Timmerman, L; McDevitt, H O et al. (1989) Molecular characterization of MHC class II antigens (beta 1 domain) in the BB diabetes-prone and -resistant rat. Immunogenetics 29:231-4
Solovera, J J; Farinas, M C; Strober, S (1988) Changes in B lymphocyte function in rheumatoid arthritis and lupus nephritis after total lymphoid irradiation. Arthritis Rheum 31:1481-91
Morel, P A; Erlich, H A; Fathman, C G (1988) A new look at the shared epitope hypothesis. Am J Med 85:20-2
Adelman, N E; Watling, D; McDevitt, H O (1988) In vivo effects of antibodies to immune response gene products. II. Suppression of humoral immune responses with monoclonal anti-I-A is due to suppressor cells. Int Rev Immunol 3:333-44
Shizuru, J A; Taylor-Edwards, C; Banks, B A et al. (1988) Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240:659-62

Showing the most recent 10 out of 26 publications